首页> 外文期刊>Circulation: An Official Journal of the American Heart Association >Hybrid open endovascular technique for aortic thoracoabdominal pathologies.
【24h】

Hybrid open endovascular technique for aortic thoracoabdominal pathologies.

机译:混合开放腔内技术治疗主动脉胸腹病变。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Many authors using a hybrid debranching strategy for the treatment of thoracoabdominal pathologies have reported disappointing results and the initial enthusiasm for the technique has given way to criticism and ambiguity. The aim of the present meta-analysis study was to assess the safety and efficacy of the technique in patients with thoracoabdominal aortic aneurysms or other aortic pathologies. METHODS AND RESULTS: A multiple electronic search was performed on all articles describing hybrid open endovascular repair. Separate meta-analyses were conducted for technical success, visceral graft patency, spinal cord ischemia symptoms, renal insufficiency, and other complications as well as 30-day/in-hospital mortality. Nineteen publications with a total of 507 patients were analyzed. The pooled estimates for primary technical success and visceral graft patency were 96.2% (95% CI, 93.5%-98.2%) and 96.5% (95% CI, 95.2%-97.8%) respectively. A pooled rate of 7.5% (95% CI, 5.0%-11.0%) for overall spinal cord ischemia symptoms was observed; whereas for irreversible paraplegia the pooled rate was 4.5% (95% CI, 2.5%-7.0%). The pooled estimate for renal failure was 8.8% (95% CI, 3.9%-15.5%). The pooled 30-day/in-hospital mortality rate was 12.8% (95% CI, 8.6%-17.0%). During the mean follow-up period of 34.5 (95% CI, 31.5-37.5) months, a total of 119 endoleaks were identified in 111 patients (22.7%). CONCLUSIONS: The repair of thoracoabdominal pathologies by means of hybrid procedures in patients who are poor surgical candidates is still associated with significant morbidity and mortality rates. Future studies may substantiate whether the technique is amenable to amelioration and improvement.
机译:背景:许多使用混合去分支策略治疗胸腹病理的作者报告了令人失望的结果,对该技术的最初热情已被批评和模棱两可的方法所取代。本荟萃分析研究的目的是评估该技术在胸腹主动脉瘤或其他主动脉病变患者中的安全性和有效性。方法和结果:对描述混合性开放性血管内修复的所有文章进行了多次电子搜索。对技术成功率,内脏移植物通畅性,脊髓缺血症状,肾功能不全和其他并发症以及30天/住院死亡率进行了单独的荟萃分析。分析了19篇出版物,共507例患者。对主要技术成功率和内脏移植物通畅性的汇总估计分别为96.2%(95%CI,93.5%-98.2%)和96.5%(95%CI,95.2%-97.8%)。观察到总体脊髓缺血症状的合并率为7.5%(95%CI,5.0%-11.0%);而对于不可逆性截瘫,合并率为4.5%(95%CI,2.5%-7.0%)。合并的肾衰竭估计值为8.8%(95%CI,3.9%-15.5%)。合并的30天/医院死亡率为12.8%(95%CI,8.6%-17.0%)。在34.5(95%CI,31.5-37.5)个月的平均随访期间,在111位患者(22.7%)中共发现119内漏。结论:在手术效果较差的患者中,通过混合手术修复胸腹病理仍然与明显的发病率和死亡率相关。未来的研究可能证实该技术是否适合改善和改进。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号